189 related articles for article (PubMed ID: 9735095)
21. Drug-induced linear IgA bullous dermatosis.
Navi D; Michael DJ; Fazel N
Dermatol Online J; 2006 Sep; 12(5):12. PubMed ID: 16962027
[TBL] [Abstract][Full Text] [Related]
22. Vancomycin-associated linear IgA dermatosis. A report of three cases.
Carpenter S; Berg D; Sidhu-Malik N; Hall RP; Rico MJ
J Am Acad Dermatol; 1992 Jan; 26(1):45-8. PubMed ID: 1531056
[TBL] [Abstract][Full Text] [Related]
23. Localized palmar vancomycin-induced linear IgA bullous dermatosis occurring at supratherapeutic levels.
Walsh SN; Kerchner K; Sangüeza OP
Arch Dermatol; 2009 May; 145(5):603-4. PubMed ID: 19451516
[No Abstract] [Full Text] [Related]
24. Drug-induced linear IgA bullous disease following antibiotics.
Wiadrowski TP; Reid CM
Australas J Dermatol; 2001 Aug; 42(3):196-9. PubMed ID: 11488715
[TBL] [Abstract][Full Text] [Related]
25. Vancomycin-induced linear IgA bullous disease.
Danielsen AG; Thomsen K
Br J Dermatol; 1999 Oct; 141(4):756-7. PubMed ID: 10583138
[No Abstract] [Full Text] [Related]
26. A case of vancomycin-associated linear IgA bullous dermatosis and IgA antibodies to the α3 subunit of laminin-332.
Zenke Y; Nakano T; Eto H; Koga H; Hashimoto T
Br J Dermatol; 2014 Apr; 170(4):965-9. PubMed ID: 24641255
[TBL] [Abstract][Full Text] [Related]
27. Moxifloxacin as the likely cause of drug-induced linear immunoglobulin A bullous dermatosis.
Kovacic D; Fox M; Reichenberg J
J Drugs Dermatol; 2008 Aug; 7(8):794-5. PubMed ID: 18720700
[TBL] [Abstract][Full Text] [Related]
28. Vancomycin-induced linear Immunoglobulin A bullous dermatosis.
Phyu H; Kobayashi T; Rastogi P; Cho C
BMJ Case Rep; 2019 Dec; 12(12):. PubMed ID: 31822537
[No Abstract] [Full Text] [Related]
29. Intertriginous bullae in a 53-year-old man.
Chang A; Camisa C; Ormsby A
Arch Dermatol; 2001 Jun; 137(6):815-20. PubMed ID: 11405780
[No Abstract] [Full Text] [Related]
30. Vancomycin-induced linear IgA bullous dermatosis presenting as generalized fixed drug eruption.
Bakke JR; Chantara A; Cash J; Fisher KR
J Cutan Pathol; 2019 Dec; 46(12):979-981. PubMed ID: 31390070
[No Abstract] [Full Text] [Related]
31. Drug-induced linear IgA bullous dermatosis after vancomycin discontinuance in a patient with renal insufficiency.
Klein PA; Callen JP
J Am Acad Dermatol; 2000 Feb; 42(2 Pt 2):316-23. PubMed ID: 10640923
[TBL] [Abstract][Full Text] [Related]
32. Childhood linear IgA bullous disease triggered by amoxicillin-clavulanic acid.
Ho JC; Ng PL; Tan SH; Giam YC
Pediatr Dermatol; 2007; 24(5):E40-3. PubMed ID: 17958778
[TBL] [Abstract][Full Text] [Related]
33. [Linear IgA bullous dermatosis: a review].
Ingen-Housz-Oro S
Ann Dermatol Venereol; 2011 Mar; 138(3):214-20. PubMed ID: 21397151
[TBL] [Abstract][Full Text] [Related]
34. Drug-induced linear IgA bullous dermatosis.
Onodera H; Mihm MC; Yoshida A; Akasaka T
J Dermatol; 2005 Sep; 32(9):759-64. PubMed ID: 16361722
[TBL] [Abstract][Full Text] [Related]
35. Linear IgA dermatosis related to vancomycin.
Piketty C; Meeus F; Nochy D; Poux JM; Jacquot C; Bariety J
Br J Dermatol; 1994 Jan; 130(1):130-1. PubMed ID: 8305307
[No Abstract] [Full Text] [Related]
36. Bullous skin disease: an unusual allergic reaction to vancomycin.
Neughebauer BI; Negron G; Pelton S; Plunkett RW; Beutner EH; Magnussen R
Am J Med Sci; 2002 May; 323(5):273-8. PubMed ID: 12018672
[TBL] [Abstract][Full Text] [Related]
37. [Vancomycin-induced linear IgA dermatosis].
Brinkmeier T; Angelkort B; Frosch PJ; Herbst RA
J Dtsch Dermatol Ges; 2003 Mar; 1(3):212-4. PubMed ID: 16285497
[TBL] [Abstract][Full Text] [Related]
38. Linear IgA bullous dermatosis occurring after carbamazepine.
Cohen LM; Ugent RB
J Am Acad Dermatol; 2002 Feb; 46(2 Suppl Case Reports):S32-3. PubMed ID: 11807466
[TBL] [Abstract][Full Text] [Related]
39. Captopril-triggered linear IgA bullous dermatosis.
Friedman IS; Rudikoff D; Phelps RG; Sapadin AN
Int J Dermatol; 1998 Aug; 37(8):608-12. PubMed ID: 9732010
[No Abstract] [Full Text] [Related]
40. Unilateral vancomycin-induced linear IgA bullous dermatosis.
Belhareth K; Soua Y; Hraeich A; Fredj NB; Badreddine S; Ali HB; Zili J
Indian J Dermatol Venereol Leprol; 2019; 85(6):621-622. PubMed ID: 31571615
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
